创新医疗
(002173)
| 流通市值：91.88亿 | | | 总市值：97.39亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 597,495,213.85 | 401,530,071.25 | 193,334,481.58 | 816,018,808.41 |
| 营业收入 | 597,495,213.85 | 401,530,071.25 | 193,334,481.58 | 816,018,808.41 |
| 二、营业总成本 | 628,500,075.15 | 414,194,757.65 | 205,240,260.34 | 875,716,000.54 |
| 营业成本 | 537,280,995.36 | 353,119,840.91 | 176,013,067.63 | 752,326,293.78 |
| 税金及附加 | 8,056,439.05 | 5,341,514.3 | 2,593,266.39 | 11,219,298.91 |
| 销售费用 | 7,388,848.39 | 4,762,324.78 | 2,151,638.32 | 9,376,130.32 |
| 管理费用 | 74,600,621.78 | 50,610,815.03 | 24,404,821.16 | 105,516,509.94 |
| 研发费用 | 567,677.09 | - | - | - |
| 财务费用 | 605,493.48 | 360,262.63 | 77,466.84 | -2,722,232.41 |
| 其中:利息费用 | 2,138,764.09 | 1,891,980.62 | 692,165.59 | 4,090,769.8 |
| 其中:利息收入 | 3,074,751.36 | 2,096,146.82 | 1,078,577.96 | 7,915,770.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,211,272.7 | 2,734,231.68 | 1,273,245.4 | 6,328,693.68 |
| 加:投资收益 | 29,505,473.85 | -2,595,176.56 | -2,098,085.95 | -4,348,134.7 |
| 资产处置收益 | 13,836.71 | 13,836.71 | - | -1,422,556.57 |
| 资产减值损失(新) | - | - | - | -205,586.91 |
| 信用减值损失(新) | 2,632,710.47 | 3,420,710.72 | -1,076,263.6 | -2,449,376.98 |
| 其他收益 | 1,592,687.35 | 497,029.14 | 287,655.62 | 1,460,767.66 |
| 四、营业利润 | 6,951,119.78 | -8,594,054.71 | -13,519,227.29 | -60,333,385.95 |
| 加:营业外收入 | 1,612,320.36 | 1,123,130.92 | 14,561.92 | 2,390,610.58 |
| 减:营业外支出 | 3,578,207.03 | 3,098,309.92 | 428,322.68 | 42,691,774.33 |
| 五、利润总额 | 4,985,233.11 | -10,569,233.71 | -13,932,988.05 | -100,634,549.7 |
| 减:所得税费用 | 316,843.36 | 622,696.64 | -42,319.74 | -6,646,277.2 |
| 六、净利润 | 4,668,389.75 | -11,191,930.35 | -13,890,668.31 | -93,988,272.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 4,668,389.75 | -11,191,930.35 | -13,890,668.31 | -93,988,272.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 4,724,431.93 | -11,361,296.28 | -13,937,418.26 | -93,954,030.31 |
| 少数股东损益 | -56,042.18 | 169,365.93 | 46,749.95 | -34,242.19 |
| 扣除非经常损益后的净利润 | -29,469,828.6 | -12,884,078.37 | -14,970,488.85 | -59,574,054.35 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | -0.03 | -0.03 | -0.21 |
| (二)稀释每股收益 | 0.01 | -0.03 | -0.03 | -0.21 |
| 九、综合收益总额 | 4,668,389.75 | -11,191,930.35 | -13,890,668.31 | -93,988,272.5 |
| 归属于母公司股东的综合收益总额 | 4,724,431.93 | -11,361,296.28 | -13,937,418.26 | -93,954,030.31 |
| 归属于少数股东的综合收益总额 | -56,042.18 | 169,365.93 | 46,749.95 | -34,242.19 |
| 公告日期 | 2025-10-25 | 2025-08-09 | 2025-04-28 | 2025-04-12 |
| 审计意见(境内) | | | | 标准无保留意见 |